4
MARKET OVERVIEW
Maps the market evolution with focus on trend catalysts, risk factors, and growth opportunities across segments.
4.2.1.1
GROWTH IN POPULATION OF COMPANION ANIMALS
4.2.1.2
INCREASING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS
4.2.2.1
RISING COST OF PET CARE
4.2.3.1
INTEGRATION OF AI AND ML
4.2.4.1
WORKFORCE SHORTAGE
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
5
INDUSTRY TRENDS
Captures industry movement, adoption patterns, and strategic signals across key end-use segments and regions.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC INDICATORS
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN US HEALTHCARE INDUSTRY
5.2.4
TRENDS IN US MEDICAL DEVICE INDUSTRY
5.3
SUPPLY CHAIN ANALYSIS
5.6.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END USER, 2023–2025
5.6.2
AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023–2025
5.6.3
AVERAGE SELLING PRICE TREND, BY APPLICATION, 2023–2025
5.7.1
IMPORT SCENARIO (HS CODE 9018)
5.7.2
EXPORT SCENARIO (HS CODE 9018)
5.8
KEY CONFERENCES AND EVENTS, 2026–2027
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.10
INVESTMENT AND FUNDING SCENARIO
5.11
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
5.12.3
PRICE IMPACT ANALYSIS
5.12.5
IMPACT ON END-USE INDUSTRIES
6
STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION
6.1.1
PORTABLE INSTRUMENTS FOR POC DIAGNOSTIC SERVICES
6.1.2
CRISPR-BASED DIAGNOSTIC SYSTEMS
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
AI-DRIVEN DIAGNOSTIC PLATFORMS
6.2.2
NEXT-GENERATION SEQUENCING (NGS)
6.3
ADJACENT TECHNOLOGIES
6.3.1
WEARABLE BIOSENSORS & REMOTE MONITORING DEVICES
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.7
IMPACT OF AI/GEN AI ON US VETERINARY DIAGNOSTICS MARKET
6.7.1
TOP USE CASES AND MARKET POTENTIAL
6.7.2
BEST PRACTICES IN US VETERINARY DIAGNOSTICS MARKET
6.7.3
CASE STUDIES: IMPLEMENTATION OF AI IN US VETERINARY DIAGNOSTICS MARKET
6.7.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.7.5
CLIENT READINESS TO ADOPT GENERATIVE AI IN US VETERINARY DIAGNOSTICS MARKET
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
7.1
REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY INITIATIVES
7.2.1
GREEN PACKAGING & WASTE FOR VETERINARY MOLECULAR DIAGNOSTICS
7.3
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.4
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
US VETERINARY DIAGNOSTICS MARKET, BY PRODUCT (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
COMPARATIVE ASSESSMENT OF KEY US VETERINARY DIAGNOSTIC PRODUCTS, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS BY VARIOUS SUPPLIER COMPANIES
Market Size, Volume & Forecast – USD Million
10
US VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
TECHNOLOGY-WISE DEMAND POTENTIAL AND GROWTH PATHWAYS SHAPING US VETERINARY DIAGNOSTIC ADOPTION IN DIVERSE INDUSTRIES
10.2.1
LATERAL FLOW ASSAY
10.2.1.1
LATERAL FLOW RAPID TEST
10.2.1.2
LATERAL FLOW STRIP READER
10.2.3
ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TEST
10.2.4
IMMUNOASSAY ANALYZER
10.2.6
OTHER IMMUNODIAGNOSTIC PRODUCTS
10.3
CLINICAL BIOCHEMISTRY
10.3.1
CLINICAL CHEMISTRY ANALYSIS
10.3.1.1
CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES
10.3.1.2
CLINICAL CHEMISTRY ANALYZER
10.3.2
GLUCOSE MONITORING
10.3.2.1
BLOOD GLUCOSE STRIP
10.3.2.3
URINE GLUCOSE STRIP
10.3.3
BLOOD GAS & ELECTROLYTE ANALYSIS
10.3.3.1
BLOOD GAS & ELECTROLYTE REAGENT AND CLIPS & CARTRIDGES
10.3.3.2
BLOOD GAS & ELECTROLYTE ANALYZER
10.4
MOLECULAR DIAGNOSTICS
10.4.3
NUCLEIC ACID SEQUENCING
10.4.4
OTHER MOLECULAR DIAGNOSTIC PRODUCTS
10.5.1
URINALYSIS CLIPS & CARTRIDGES/PANELS
10.6.1
HEMATOLOGY CARTRIDGES
10.6.2
HEMATOLOGY ANALYZERS
• OTHER IMMUNODIAGNOSTIC PRODUCTS INCLUDE ASSAY TESTS SUCH AS AGGLUTINATION TESTS, FLUORINATED AGGLUTINATION TESTS (FAT), IMMUNOHISTOCHEMISTRY, WESTERN BLOT TESTS, NON-INFECTION IMMUNOASSAYS, COMPLEMENT FIXATION, AGAR GEL IMMUNODIFFUSION, AND SERUM/VIRUS
• OTHER MOLECULAR DIAGNOSTIC PRODUCTS INCLUDE DNA SEQUENCING, GENOTYPING, PROFILING, AND NEXT-GENERATION SEQUENCING PRODUCTS.
Growth opportunities and latent adjacency in US Veterinary Diagnostics Market